Plasmid pECV was made by first amplifying a LacZ fragment by PCR from pUC19 using primers ecv1 (
Kanamycin Resistance
This resistance can occur through various mechanisms, including the production of enzymes that inactivate the antibiotic, modifications to the antibiotic target, or changes in membrane permeability.
Understanding and studying Kanamycin Resistance is crucial for developing effective treatments, preventing the spread of resistant infections, and optimizing research protocols.
PubCompare.ai, an AI-driven platform, can assist researchers in locating the best protocols from literature, pre-prints, and patents, enhancing reproducibility and accuaracy with personalized recommendations tailored to their research needs.
Most cited protocols related to «Kanamycin Resistance»
Plasmid pECV was made by first amplifying a LacZ fragment by PCR from pUC19 using primers ecv1 (
To provide conjugation as an alternative way to introduce these plasmids into bacterial strains, we cloned the oriT site from the RP4 plasmid sequences in the strain SM10 [24 (link)]. oriT was amplified by PCR using primers GGCGCCGGCCAGCCTCGCAGAGCA and GGCGCCGGGCAGGATAGGTGAAGT, and cloned into pCR2.1-topo using the Topo TA cloning kit (Invitrogen). The sequence and transfer activity was confirmed, then the oriT sequence was moved by moving the 113 bp SfoI fragment into the NaeI site (resulting in the plasmid in parentheses) of pGRG6 (pGRG19), pGRG8 (pGRG20), and pGRG17 (pGRG25). pGRG36 is identical to pGRG25, except that it contains a SmaI site in the multiple cloning site. Both pGRG25 and pGRG36 sequences can be downloaded at GenBank using NCBI accession # DQ460223. The ability of the delivery plasmids to be transferred by conjugation was confirmed using pGRG25-containing SM10 as donor in a standard conjugation assay at 32°C [25 ].
To facilitate the cloning of large fragments into the delivery vehicle we cloned the RfC.1 element from the Gateway cloning system (Invitrogen) into the SmaI site of pGRG36, yielding pGRG37. This allows in vitro movement of transgenes cloned in Gateway cloning vectors into pGRG37, bypassing the need for standard cloning techniques [26 (link)].
Plasmid constructs contained the following elements: promoter-TACTAGAG-B0032-TACTAG-ORF(dsRed, GFP, Gemini)-TACTAGAG-B0015, where the ORF was exchanged using standard PCR-based techniques. For chromosomal insertions, test constructs were fused to a kanamycin resistance marker (Bba_P1003, Registry of Standard Biological Parts,
tonB-BioBrickPrefix-fwd
BioBrickSuffix-rev
cgaacttttgctgagttgaaggatcagCTGCAGCGGCCGCTACTAGTA
BioBrickSuffix-fwd
TACTAGTAGCGGCCGCTGCAGctgatccttcaactcagcaaaagttcg
P1003-tonB-rev
Two strains were used to control for cellular auto-fluorescence. DH5α transformed with pSB3C5 was used as a negative control for experiments using plasmid-based constructs. For experiments testing promoter function from the tonB locus, the kanamycin resistance marker with no reporter construct was recombined downstream of the tonB locus using primers tonB-BioBrickPrefix-fwd, P1003-tonB-rev.
Most recents protocols related to «Kanamycin Resistance»
Example 7
Sepsis modeling was performed as described by Gorringe A. R., Reddin, K. M., Voet P. and Poolman J. T. (Methods Mol. Med. 66, 241 (Jan. 1, 2001)) and Johswich, K. O. et al. (Infect. Immun. 80, 2346 (Jul. 1, 2012)). Groups of 6 eight-week-old C57BL/6 mice (Charles River Laboratories) were inoculated via intraperitoneal injection with N. meningitidis strain B16B6, B16B6 Δtbpb, or B16B6 Δnmb0313 (N=2 independent experiments). To prepare inoculums, bacterial strains for infection were grown overnight on GC agar, resuspended and then grown for 4 h in 10 ml of Brain Heart Infusion (BHI) medium at 37° C. with shaking. Cultures were adjusted such that each final 500 μl inoculum contained 1×106 colony forming units and 10 mg human holo-transferrin. Mice were monitored at least every 12 h starting 48 h before infection to 48 h after infection for changes in weight, clinical symptoms and bacteremia. Mice were scored on a scale of 0-2 based on the severity of the following clinical symptoms: grooming, posture, appearance of eyes and nose, breathing, dehydration, diarrhea, unprovoked behavior, and provoked behavior. Animals reaching endpoint criteria were humanely euthanized. Animal experiments were conducted in accordance with the Animal Ethics Review Committee of the University of Toronto.
The entire erm37 gene, including its own promoter, was PCR amplified using oligonucleotides 2 and 5: ATCGTCGCGGCCGCGATATCGCCTCATTGGC, as described above, and cloned in between the NotI and HindIII sites in the same vector. All the molecular biology cloning experiments were performed according to the manufacturer recommendations. We used E. coli Top10 cells (Invitrogen) for cloning experiments. We prepared and transformed M. bovis BCG by electroporation as described,56 (link) using 200μl aliquots stored in 10% glycerol at -80°C, except that bacteria were recovered in 1ml SOC medium (Sigma) for 6h at 37°C. Then, M. bovis BCG transformed bacteria were cultivated in the presence of 20μg/ml kanamycin.
The gene coding for γ-glutamyl phosphate reductase was ligated into the pHTP1 expression vector (GenScript Biotech) producing a recombinant protein that contains an N-terminal hexahistidine and Kanamycin resistance.
All the recombinant proteins were transformed and expressed in E.coli BL21 (DE3) (Invitrogen, USA).
Top products related to «Kanamycin Resistance»
More about "Kanamycin Resistance"
This resistance can occur through various mechanisms, including the production of enzymes that inactivate the antibiotic, modifications to the antibiotic target, or changes in membrane permeability.
Understanding and studying Kanamycin Resistance is crucial for developing effective treatments, preventing the spread of resistant infections, and optimizing research protocols.
The PGEM-T Easy vector and PGEM-T Easy are commonly used plasmids that confer Kanamycin Resistance, allowing for the selection of transformed bacterial cells.
Similarly, the Gibson Assembly and GeneArt methods can be employed to construct DNA sequences with Kanamycin Resistance genes.
Phusion High-Fidelity DNA Polymerase and the Q5 Site-Directed Mutagenesis Kit are valuable tools for amplifying and modifying DNA, including Kanamycin Resistance genes.
Researchers can utilize the AI-driven platform PubCompare.ai to locate the best protocols from literature, preprints, and patents related to Kanamycin Resistance.
This platform can enhance reproducibility and accuaracy by providing personalized recommendations tailored to their specific research needs.
The PVAX1 vector and the MicroPulser electroporation device are additional resources that may be relevant for Kanamycin Resistance research and applications.
By understanding the various aspects of Kanamycin Resistance, scientists can develop more effective treatments, prevent the spread of resistant infections, and optimize their research protocols, ultimately contributing to advancements in the field of microbiology and biotechnology.